Section 1: Introductory Statements and Governance |
S11 The pharmacists in our hospital work routinely as part of multidisciplinary team (41% of all responses were negative) |
S13 Our hospital is able prioritise hospital pharmacy activities according to agreed criteria (23% of all responses were negative) |
S15 The pharmacists in our hospital are engaged in the supervision of all steps of all medicine use processes (24% of all responses were negative) |
S16 At least one pharmacist from our team is a full member of the Drug and Therapeutics Committee (11% of all responses were negative) |
S162 The pharmacists in our hospital take the lead in coordinating the activities of the Drug and Therapeutics Committees (26% of all responses were negative) |
S17 The pharmacists in our hospital are involved in the design, specification of parameters and evaluation of ICT used within medicines processes (27% of all responses were negative) |
Section 2: Selection, Procurement and Distribution |
S21 Our hospital has clear processes in place around the procurement of medicines (4% of all responses were negative) |
S212 Were hospital pharmacists involved in the development of these? (6% of all responses were negative) |
S22 The pharmacists in our hospital take the lead in developing, monitoring, reviewing and improving medicine use processes and the use of medicine-related technologies (19% of all responses were negative) |
S23 The pharmacists in our hospital coordinate the development, maintenance and use of our formulary (16% of all responses were negative) |
S24 Procurement of non-formulary medicines in our hospital is done to a robust process (9% of all responses were negative) |
S25 The pharmacy in our hospital has contingency plans for medicines shortages (30% of all responses were negative) |
S26 The pharmacy in our hospital takes responsibility for all medicines logistics, including for investigational medicines (8% of all responses were negative) |
S27 Our hospital has a policy for the use of medicines brought into the hospital by patients (28% of all responses were negative) |
S272 Were pharmacists involved in producing this policy? (16% of all responses were negative) |
Section 3: Production and Compounding |
S31 The pharmacists in our hospital check if a suitable product is commercially available before we manufacture or prepare a medicine (8% of all responses were negative) |
S32 When medicines require manufacture or compounding, we either produce them in our hospital pharmacy or we outsource to an approved provider (9% of all responses were negative) |
S33 The pharmacists in our hospital undertake a risk assessment to determine the best practice quality requirements before making a pharmacy preparation (16% of all responses were negative) |
S34 The pharmacy in our hospital has an appropriate system in place for the quality assurance of pharmacy prepared and compounded medicines (24% of all responses were negative) |
S342 The pharmacy in our hospital has an appropriate system in place for the traceability of pharmacy prepared and compounded medicines (17% of all responses were negative) |
S35 Our hospital has appropriate systems in place for the preparation and supply of hazardous medicines (26% of all responses were negative) |
S36 Our hospital has written procedures that ensure staff are appropriately trained to reconstitute or mix medicines in a patient care area (25% of all responses were negative) |
S362 Were pharmacists involved in approving these procedures? (28% of all responses were negative) |
Section 4: Clinical Pharmacy Services |
S41 The pharmacists in our hospital play a full part in shared decision-making on medicines, including advising, implementing and monitoring medication changes (31% of all responses were negative) |
S42 All prescriptions in our hospital are reviewed and validated as soon as possible by a pharmacist (37% of all responses were negative) |
S43 The pharmacists in our hospital have access to the patients’ health record (34% of all responses were negative) |
S432 The pharmacists in our hospital can document their clinical interventions into the patients’ health record (44% of all responses were negative) |
S434 We analyse clinical pharmacy interventions to inform quality improvement plans (14% of responses were negative) |
S44 The pharmacists in our hospital enter all medicines used onto the patient's medical record on admission (71% of all responses were negative) |
S442 The pharmacists in our hospital reconcile medicines on admission (22% of all responses were negative) |
S444 The pharmacists in our hospital assess the appropriateness of all patients’ medicines, including herbal and dietary supplements (9% of all responses were negative) |
S45 The pharmacists in our hospital contribute to the transfer of information about medicines when patients move between and within healthcare settings (56% of all responses were negative) |
S46 The pharmacists in our hospital ensure patients and carers are offered information about their medicines in terms they can understand (36% of all responses were negative) |
Section 5: Patient Safety and Quality Assurance |
S52 Our hospital has appropriate strategies to detect errors and identify priorities for improvement in medicines use processes (21% of all responses were negative) |
S522 Were pharmacists involved in approving these procedures? (18% of all responses were negative) |
S53 Our hospital uses an external quality assessment accreditation programme to assure our medicines use processes (48% of all responses were negative) |
S532 Our hospital acts on these reports to improve the quality and safety of our medicines use processes (29% of all responses were negative) |
S54 The pharmacists in our hospital report adverse drug reactions (24% of all responses were negative) |
S542 The pharmacists in our hospital report medication errors (32% of all responses were negative) |
S55 The pharmacists in our hospital use evidence-based approaches to reduce the risk of medication errors (21% of all responses were negative) |
S552 Our hospital pharmacy uses computerised decision support to reduce the risk of medication errors (39% of all responses were negative) |
S56 Our hospital has appropriate procedures in place to identify high-risk medicines and minimise risk from their use (19% of all responses were negative) |
S562 Are pharmacists involved in implementing these procedures? (7% of all responses were negative) |
S57 The medicines administration process in our hospital ensures that transcription steps between the original prescription and the medicines administration record are eliminated (31% of all responses were negative) |
S58 Our patient's health records accurately record all allergy and other relevant medicine-related information (12% of all responses were negative) |
S59 The pharmacists in our hospital ensure that the information needed for safe medicines use is accessible at the point of care (13% of all responses were negative) |
S510 Medicines in our hospital are packaged and labelled to assure they are safely optimised for administration (11% of all responses were negative) |
S511 Medicines dispensed by our pharmacy are traceable (12% of all responses were negative) |
Section 6: Education and Research |
S62 The pharmacists in our hospital are able to demonstrate their competence to perform their roles (7% of all responses were negative) |
S63 Pharmacists in our hospital are able to engage in relevant educational opportunities (5% of responses were negative) |
S64 The pharmacists in our hospital routinely publish hospital pharmacy practice research (51% of all responses were negative) |